The Scientific Research Team at Mythic Therapeutics is dedicated to advancing the company's FateControl technology, focusing on the development and optimization of Antibody Drug Conjugates (ADCs) that specifically target and eliminate cancer cells while sparing healthy tissues. This team collaborates across disciplines, leveraging expertise in biology, antibody engineering, and protein sciences to drive innovative research and facilitate the translation of scientific discoveries into effective cancer therapies.
Brian Fiske
Chief Scientific Officer & Co-...
Douglas Williams
Scientific Advisor
Ji Yeon Lee
Senior Associate Scientist, An...
John Lambert
Scientific Advisor
Lihui Xu
Director, Antibody Engineering
Michael Vasconcelles
Scientific Advisor
Richard Gregory
Scientific Advisor
Scott Dylla
Scientific Advisor
Tom Chittenden
SVP & Head of Biology
View all